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ABSTRACT 
In this review, the various new and well established technologies relevant to the controlled and targeted drug delivery systems have been precisely discussed. 
A perfectly designed controlled drug delivery system can be of huge advantage towards solving problems concerning to the targeting of drug to a specific 
organ or tissue and controlling the rate of drug delivery at the target site. Novel drug delivery systems have various advantages over other conventional drug 
therapy. In which microencapsulation is one approach for achieving the novel drug delivery dosage forms such as sustained release and controlled release, 
though the development of oral controlled release systems has been a challenge to formulation scientist due to their inability to restrain and focus the system at 
targeted areas of gastrointestinal tract. Microparticulate drug delivery systems are an interesting and promising option when developing an oral controlled 
release system. Our objective is to take a closer look at microparticles as drug delivery devices for increasing efficiency of drug delivery, improving the release 
profile and drug targeting. In order to elucidate the application of microcapsules in drug delivery, some fundamental aspects are briefly reviewed. 
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INTRODUCTION 
Microencapsulation is one of the most promising fields in the 
area of pharmaceutical technology since its inception many 
years ago. Nowadays the microencapsulation is extensively 
studied  inside  major  pharmaceutical  companies  and 
universities  as  well  as  research  institutes.  Polymeric  drug 
delivery devices are focusing on the encapsulation of large 
molecules,  e.g.,  peptides,  proteins,  and  DNA/RNA  for 
potential  use  as  vaccines  or  as  long-acting  release  drug 
formulations.  Importantly,  some  of  these  initiatives  led  to 
important pharmaceutical products and most of them are still 
on  the  market  (e.g.,  Lupron  Depot®,  Zoladex®, 
Decapeptyl®, Eligard®, Enantone®, Trenantone®, Nutropin 
Depot®,  and  Profact®). 
1  In  addition,  encapsulation  for 
controlling  the  release  of  highly  water  soluble  drugs  has 
received much attention. This article reviews the current state 
of the art in emulsion solvent evaporation/extraction based 
microencapsulation  technologies.  It  is  focused  on  the 
formulation,  optimization  and  the  drug  delivery  related 
aspects rather than equipments and machinery, as described 
in the most recent and early pioneered patents and the most 
related  articles  in  the  literature.  Both,  well-established  and 
more  advanced  technologies  are  reviewed. 
Microencapsulation processes based on solvent removal from 
emulsions  have  been  reviewed  in  various  books 
2-4  and 
review articles.
5-10  
Micro-encapsulation is a process in which tiny particles or 
droplets are surrounded by a coating to give small capsules 
with many useful properties. In a relatively simplistic form, a 
microcapsule is a small sphere with a uniform wall around 
it. The material inside the microcapsule is referred to as the 
core, internal phase, or fill, whereas the wall is sometimes 
called  a  shell,  coating,  or  membrane.  Most  microcapsules 
have  diameters  between  a  few  micrometers  and  a  few 
millimeters.
11 
The microencapsulation procedure was firstly discovered by 
Bungen burg de Jon and Kan in 1931 and which were deal 
with the preparation of gelatin spheres through a coacervation 
process.  During  the  past  decades,  there  has  been  an 
increasing  interest  in  optimizing  the  efficiency  of  existing 
drugs  through  the  use  of  better-designed  drug  delivery 
systems.  The  majority  of  these  systems  are  based  on 
polymers that differ in their permeability, rate of dissolution, 
degree of swelling and erodibility. 
It  is  generally  accepted  that  microencapsulation  products 
(microparticles) are larger than 1 micrometer in diameter and 
can be up to 1000 micrometers. Commercial microparticles 
have a diameter range 3 to 800 micrometers and contain 10-
90%  w/w  core.  A  wide  range  of  core  materials  has  been 
encapsulated, including adhesives, agrochemicals, live cells, 
active enzymes, flavors, fragrances, pharmaceuticals and ink. 
Morphologically, two general structures exist: microcapsules 
and  microspheres.  A  microcapsule  is  a  reservoir-type 
system with regular or irregular shapes that contains a well 
defined core and envelope. The core can be solid, liquid, or 
gas;  the  envelope  is  made  of  a  continuous,  porous  or 
nonporous,  polymeric  phase  created  by  one  or  more 
polymers. Alternatively, a microsphere is a homogeneous or 
monolithic structure made of a continuous phase of one or 
more  miscible  polymers  in  which  particulate  drug  is 
dispersed  throughout  the  matrix,  at  either  the  macroscopic 
(particulates) or molecular (dissolution) level. 
Classification 
Microcapsules  can  be  classified  on  three  basic  categories, 
they are as follows: 
1. Mononuclear 
2. Polynuclear 
3. Matrix types 
Mononuclear  (core-shell)  microcapsules  contain  the  shell 
around the core, while Polynuclear capsules have many cores 
enclosed within the shell. In matrix encapsulation, the core 
material is distributed homogeneously into the shell material. 
In addition to these three basic morphologies, microcapsules Malakar Jadupati et al. IRJP 2012, 3 (4) 
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can also be mononuclear with multiple shells, or they may 
form clusters of microcapsules.
12 
The  scanning  electron  microscopy  (SEM)  has revealed  the 
structural  features  of  microcapsules  as  to  be  varying  and 
complex.  The  walled  prototype  may  be  mononuclear  as 
shown in Figure 1(a) or may have multiple core structure 
13 
and
  also  double  or  multiple  concentric  coating  may  be 
present. 
14 Aggregated microcapsules greatly vary in size and 
shape  [Fig.  1(b)]  and  may  also  posses  additional  external 
wall. The perfect microcapsules are obtainable by using the 
liquid  cores  or  forming  the  microcapsules  as  a  liquid 
dispersed  phase  prior  to  the  solidification.
15  Although 
microstructure of both membrane and interior can be detected 
by SEM of surfaces  or sections [Fig. 1(c)]
16 their physical 
quality  is  difficult  to  characterize  quantitatively  in 
microcapsules  involving  measurements  of  porosity, 
tortuousity  and  crystallinity,  though  some  of  progress  has 
been  made  and  efforts  are  continuing  to  calculate 
permeability  and  porosity  from  release  data,  dimensions, 
densities, and core/wall ratios.
17 The effect of size and shape 
distribution has only been studied recently. 
 
   
Figure 1(a): Mononuclear microcapsule    
Figure 1(b): Polynuclear microcapsule 
 
 
Figure 1(c): Cross sectional view microbeads. 
 
Reasons for Microencapsulation  
The main reason for microencapsulation is for sustained or 
prolonged release of the drug.  
·  This  technique  has  been  widely  used  for  masking  the 
organoleptic properties like taste and odor of many drugs and 
thus  improves  patient  compliance  e.g.  Paracetamol, 
nitrofurantoin for masking the bitter taste.  
·  By using microencapsulation techniques the liquid drugs 
can be converted in a free flowing powder. 
·  The drugs can be protected by microencapsulation which 
is sensitive to moisture, light and oxygen, such as nifedipine 
is protected from photo instability. 
·  Microencapsulation technique also helpful to prevent the 
incompability between drugs  
·  The drugs which are volatile in nature may vaporize at 
room  temperature  like  Aspirin  and  peppermint  oil  can  be 
prevented by microencapsulation.  
·  Reduction  in  toxicity  and  GI  irritation  including  with 
KCL  and  ferrous  sulphate  can  be  achieved  by 
microencapsulation  
·  Microencapsulation has also been employed to change the 
site of absorption. This application has been useful for those 
drugs which have the toxicity at lower pH.  
·  Bakan  and  Anderson  were  reported  that 
microencapsulated  vitamin  A  palmitate  had  enhanced 
stability, as prevent from oxidation.  
·  Microencapsulation  method  has  also  been  employed  to 
prepare intrauterine contraceptive device.
 18 
MATERIALS USED FOR MICROENCAPSULATION 
Preparation  of  microspheres  should  satisfy  certain  criteria, 
like  basic  understanding  of  the  general  properties  of 
microcapsules,  such  as  the  nature  of  the  core  and  coating 
materials. 
Core Material 
The  core  material  defined  as  the  specific  material  to  be 
coated can be liquid or solid in nature. The composition of 
the core material is varied, as the liquids core can include 
dispersed and/or dissolved material. The solid core can be a 
mixture of active constituents, stabilizers, diluents, recipients 
and release-rate retardants or accelerators. The ability to vary 
the core material composition provides definite flexibility and 
utilization of this characteristic often allows effectual design 
and development of the desired microcapsule properties. 
Coating Materials 
The coating material should be capable of forming a film that 
is cohesive with the core material; be chemically compatible 
and  nonreactive  with  the  core  material;  and  provide  the 
desired  coating  properties,  such  as  strength,  flexibility, 
impermeability, optical properties, and stability. The coating 
materials used in microencapsulation methods are amenable, 
to some extent, to in-situ modification. 
The selection of a given coating often can be aided by the 
review of existing literature and by the study of free or cast 
films, although practical use of free-film information often is 
impeded for the following reasons: 
1.  Cast  or  free  films  prepared  by  the  usual  casting 
techniques yield films that are considerably thicker than 
those  produced  by  the  microencapsulation  of  small 
particles; hence, the results obtained from the cast films 
may not be extrapolate to the thin microcapsule coatings. 
2.  The particular microencapsulation method employed for 
the deposition of a given coating produces specific and 
inherent  properties  that  are  difficult  to  simulate  with 
existing film-casting methods. 
3.  The  coating  substrate  of  core  material  may  have  a 
decisive effect on coating properties. Hence, the selection 
of a particular coating material involves consideration of 
both classic free-film data and applied results. 
4.  The coating material should be capable of forming a film 
that is cohesive with the core material. 
5.  Be chemically compatible and nonreactive with the core 
material. 
6.  Provide the desired coating properties, such as strength, 
flexibility,  impermeability,  optical  properties,  and 
stability. 
19 Malakar Jadupati et al. IRJP 2012, 3 (4) 
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The  different  coating  materials  used  in 
microencapsulation  are  classified  into  following 
categories:  
1.  Vegetable  Gums:  such  as,  gum  Arabic,  agar,  sodium 
alginate, and carrageenan and dextran sulphate.  
2.  Celluloses:  such  as,  ethyl  cellulose,  nitrocellulose, 
carboxy methylcellulose, cellulose        acetate phthalate 
and cellulose acetate butyrate phthalate.  
3.  Condensation  polymers:  such  as  nylon,  Teflon, 
polymethane,  polycarbonate,  amino  resins,  alkyl  resins 
and silicone resins.  
4.  Homopolymer: such as, poly vinyl chloride, polyethylene, 
polystyrene, poly vinyl acetate and poly vinyl alcohol.  
5.  Copolymers:  such  as  maleic  anhydride  copolymer  with 
ethylene or vinyl methyl ether, acrylic acid copolymers 
and methacrylic acid co-polymers (eudragit).  
6.  Proteins:  such  as  collagen,  gelatin,  casein,  fibrinogen, 
hemoglobin and poly amino acids. Waxes: such as wax, 
paraffin,  rosin  shellac,  tristerium,  monoglyceride,  bees 
wax, oils, fats and hardened oils.  
7.  Curable  polymers:  such  as,  epoxy  resins, nitro  paraffin 
and nitrated polystyrene. 
20 
Methods used for microencapsulation:  
1.  Air suspension  
2.  Coacervation phase separation  
3.  Centrifugal Extrusion process  
4.  Spray drying and congealing  
5.  Pan coating  
6.  Solvent evaporation techniques  
7.  Polymerization 
1. Air suspension  
Air-suspension  coating  of  particles  by  solutions  or  melts 
gives better control and flexibility. The particles are coated 
while suspended in an upward-moving air stream. They are 
supported by a perforated plate having different patterns of 
holes inside and outside a cylindrical insert. Just sufficient air 
is permitted to rise through the outer annular space to fluidize 
the settling particles. Most of the rising air (usually heated) 
flows inside the cylinder, causing the particles to rise rapidly. 
At the top, as the air stream diverges and slows, they settle 
back onto the outer bed and move downward to repeat the 
cycle.  The  particles  pass  through  the  inner  cylinder  many 
times in a few minutes methods. The air suspension process 
offers  a  wide  variety  of  coating  materials  candidates  for 
microencapsulation.  The  process  has  the  capability  of 
applying coatings in the form of solvent solutions, aqueous 
solution,  emulsions,  dispersions  or hot  melts  in  equipment 
ranging in capacities from one pound to 990 pounds. Core 
materials comprised of micron or submicron particles can be 
effectively  encapsulated  by  air  suspension  techniques,  but 
agglomeration of the particles to some larger size is normally 
achieved 
[21]. 
2. Coacervation phase separation 
The general outline of the processes consists of three steps 
carried out under continuous agitation. 
i) Formation of three immiscible chemical phases: A liquid 
manufacturing  vehicle  phase,  a  core  material  phase,  and  a 
coating material phase. To form the three phases, the core 
material dispersed in a solution of the coating polymer, the 
solvent  for  the  polymer  being  the  liquid  manufacturing 
vehicle  phase.  The  coating  material  phase,  an  immiscible 
polymer in a liquid state, is formed by utilizing one of the 
methods  of  the  methods  of  phase  separation-coacervation, 
i.e., by changing the temperature of the polymer solution; or 
by adding a salt, nonsolvent, or incompatible polymer to the 
polymer  solution;  or  by  inducing  a  polymer-polymer 
interaction. 
ii) Deposition of the coating: It consists of depositing the 
liquid  polymer  coating  upon  the  core  material.  This  is 
accomplished by controlled, physical mixing of the material 
in  the  manufacturing  vehicle.  Deposition  if  the  liquid 
polymer  coating  around  the  core  material  occurs  if  the 
polymer is adsorbed at the interface formed between the core 
material  and  the  liquid  vehicle  phase,  and  this  adsorption 
phenomenon  is  a  prerequisite  to  effective  coating.  The 
continued deposition of the coating material is promoted by a 
reduction in the total free interfacial energy  of the system, 
brought about by the decrease of the coating material surface 
area during coalescence of the liquid polymer droplets. 
iii)  Rigidization  of  the  coating:  It  involves  rigidizing  the 
coating,  usually  by  thermal,  cross-linking,  or  desolvation 
techniques, to form a self-sustaining microcapsules. 
19 
3. Centrifugal extrusion 
Liquids  are  encapsulated  using  a  rotating  extrusion  head 
containing concentric nozzles. In this process, a jet of core 
liquid is surrounded by a sheath of wall solution or melt. As 
the jet moves through the air it breaks, owing to Rayleigh 
instability, into droplets of core, each coated with the wall 
solution. While the droplets are in flight, a molten wall may 
be hardened or a solvent may be evaporated from the wall 
solution. Since most of the droplets are within ± 10% of the 
mean diameter, they land in a narrow ring around the spray 
nozzle. Hence, if needed, the capsules can be hardened after 
formation by catching them in a ring-shaped hardening bath. 
This process is excellent for forming particles 400–2,000μm 
(16–79 mils) in diameter. Since the drops are formed by the 
breakup of a liquid jet, the process is only suitable for liquid 
or slurry. A high production rate can be achieved, i.e., up to 
22.5 kg (50 lb) of microcapsules can be produced per nozzle 
per hour per head. Heads containing 16 nozzles are available. 
21 
4. Spray drying and Congealing 
Spray drying serves as a microencapsulation technique when 
an  active  material  is  dissolved  or  suspended  in  a  melt  or 
polymer solution and becomes trapped in the dried particle. 
The main advantages is the ability to handle labile materials 
because of the short contact time in the dryer, in addition, the 
operation is economical. In modern spray dryers the viscosity 
of the solutions to be sprayed can be as high as 300mPas. 
Spray drying and spray congealing processes are similar in 
that both involve dispersing the core material in a liquefied 
coating  substance  and  spraying  or  introducing  the  core  - 
coating mixture into some environmental condition, whereby, 
relatively rapid solidification (and formation) of the coating 
is affected. The principal difference between the two methods 
is the means by which coating solidification is accomplished. 
Coating solidification in the case of spray drying is affected 
by  rapid  evaporation  of  a  solvent  in  which  the  coating 
material  is  dissolved.  Coating  solidification  in  spray 
congealing methods, however, is accomplished by thermally 
congealing  a  molten  coating  material  or  by  solidifying  a 
dissolved coating by introducing the coating - core material 
mixture  into  a  nonsolvent.  Removal  of  the  nonsolvent  or 
solvent  from  the  coated  product  is  then  accomplished  by 
sorption, extraction, or evaporation techniques. Malakar Jadupati et al. IRJP 2012, 3 (4) 
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In practice, microencapsulation by spray drying is conducted 
by dispersing a core material in a coating solution, in which 
the  coating  substance  is  dissolved  and  in  which  the  core 
material is insoluble, and then by atomizing the mixture into 
air stream. The air, usually heated, supplies the latent heat of 
vaporization required to remove the solvent from the coating 
material,  thus  forming  the  microencapsulated  product.  The 
equipment components of a standard spray dryer include an 
air  heater,  atomizer,  main  spray  chamber,  blower  or  fan, 
cyclone and product collector.  
Microencapsulation  by  spray  congealing  can  be 
accomplished  with  spray  drying  equipment  when  the 
protective  coating  is  applied  as  a  melt.  General  process 
variables  and  conditions  are  quite  similar  to  those  already 
described,  except  that  the  core  material  is  dispersed  in  a 
coating material melt rather than a coating solution. Coating 
solidification  (and  microencapsulation)  is  accomplished  by 
spraying the hot mixture into a cool air stream. Waxes, fatty 
acids and alcohols, polymers and sugars, which are solids at 
room  temperature  but  melt at reasonable  temperatures,  are 
applicable  to  spray  congealing  techniques.  Typically,  the 
particle size of spray congealed products can be accurately 
controlled  when  spray  drying  equipment  is  used,  and  has 
been found to be a function of the feed rate, the atomizing 
wheel  velocity,  dispersion  of  feed  material  viscosity,  and 
variables.
 19 
5. Pan coating 
The pan coating process, widely used in the pharmaceutical 
industry,  is  among  the  oldest  industrial  procedures  for 
forming small, coated particles or tablets. The particles are 
tumbled in a pan or other device while the coating material is 
applied slowly.  
The pan coating process, widely used in the pharmaceutical 
industry,  is  among  the  oldest  industrial  procedures  for 
forming small, coated particles or tablets. The particles are 
tumbled in a pan or other device while the coating material is 
applied  slowly  with  respect  to  microencapsulation,  solid 
particles  greater  than  600  microns  in  size  are  generally 
considered essential for effective coating, and the process has 
been extensively employed for the preparation of controlled - 
release beads. Medicaments are usually coated onto various 
spherical substrates such as nonpareil sugar seeds, and then 
coated with protective layers of various polymers. 
In  practice,  the  coating  is  applied  as  a  solution,  or  as  an 
atomized  spray,  to  the  desired  solid  core  material  in  the 
coating pans. Usually, to remove the coating solvent, warm 
air is  passed  over  the  coated  materials  as the  coatings  are 
being applied in the coating pans. In some cases, final solvent 
removal is accomplished in a drying oven. 
19, 21 
6. Solvent Evaporation Techniques 
Solvent  evaporation  techniques  are  performed  in  a  liquid 
manufacturing vehicle (O/W emulsion) which is formed by 
agitation  of  two  immiscible  liquids.  In  this  process 
microcapsule  coating  (polymer)  is  dissolved  in  a  volatile 
solvent, which is immiscible with the liquid manufacturing 
vehicle  phase.  A  core  material  to  be  microencapsulated  is 
dispersed  in  the  coating  polymer  solution.  To  obtain  the 
microcapsule  of  appropriate  size  the  core  and  coating 
material  mixture  is  dispersed  in  the  liquid  manufacturing 
vehicle  phase  with  agitation.  The  agitation  of  system  is 
constant till the solvent partitions into the aqueous phase and 
aqueous phase is removed by  evaporation. Various process 
variables that could affect the process of microencapsulation 
include methods of forming dispersions, evaporation rate of 
the solvent for the coating polymer, temperature cycles and 
agitation  rates.  Important  factors  that  must  be  considered 
when  preparing  microcapsules  by  solvent  evaporation 
techniques include choice of vehicle phase and solvent for the 
polymer  coating,  as  these  choices  greatly  influence 
microcapsule  properties  as  well  as  the  choice  of  solvent 
recovery  techniques  .This  technique  to  produce 
microcapsules is applicable to liquid and solid core material. 
Water soluble or water insoluble materials are used as core 
materials. A variety of film forming polymers can be used as 
coating materials. 
19 
7. Polymerization 
i) Interfacial polymer 
In  Interfacial  polymerization,  the  two  reactants  in  a 
polycondensation meet at an interface and react rapidly. The 
basis  of  this  method  is  the  classical  Schotten  Baumann 
reaction between an acid chloride and a compound containing 
an  active  hydrogen  atom,  such  as  an  amine  or  alcohol, 
polyesters,  polyurea,  polyurethane.  Under  the  right 
conditions, thin flexible walls form rapidly at the interface. A 
solution of the pesticide and a di-acid chloride are emulsified 
in water and an aqueous solution containing an amine and a 
polyfunctional  isocyanate  is  added.  Base  is  present  to 
neutralize  the  acid  formed  during  the  reaction.  Condensed 
polymer  walls  form  instantaneously  at  the  interface  of  the 
emulsion droplets. 
ii) In-situ polymerization 
In  a  few  microencapsulation  processes,  the  direct 
polymerization  of  a  single  monomer  is  carried  out  on  the 
particle  surface.  In  one  process,  e.g.  Cellulose  fibers  are 
encapsulated in polyethylene while immersed in dry toluene. 
Usual  deposition  rates  are  about  0.5μm/min.  Coating 
thickness ranges 0.2-75μm. The coating is uniform, even over 
sharp projections. 
iii) Matrix polymer 
In a number of processes, a core material is imbedded in a 
polymeric matrix during formation of the particles. A simple 
method of this type is spray-drying, in which the particle is 
formed  by  evaporation  of  the  solvent  from  the  matrix 
material. However, the solidification of the matrix also can be 
caused by a chemical change. 
21 
RELEASE MECHANISMS 
Mechanisms of drug release from microspheres are 
1. Degradation controlled monolithic system:  
The drug is dissolved in matrix and is distributed uniformly 
throughout. The drug is strongly attached to the matrix and is 
released on degradation of the matrix. The diffusion of the 
drug is slow as compared with degradation of the matrix 
2. Diffusion: 
It’s  the  most  commonly  involved  mechanism  wherein  the 
dissolution fluid penetrates the shell, dissolves the core and 
leak out through the interstitial channels or pores.
22 Thus, the 
overall release depends on, (1) the rate at which dissolution 
fluid  penetrates  the  wall  of  microcapsules,  (2)  the  rate  at 
which drug dissolves in the dissolution fluid, and (3) the rate 
at which the dissolved drug leak out and disperse from the 
surface. 
23 
The kinetics of such drug release obeys Higuchi’s equation 
24 
as below:  
Q = [D/J (2A – ε C
S
) C
S 
t]
½ 
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Where  Q  is  the  amount  of  drug  released  per  unit  area  of 
exposed surface in time t; D is the diffusion coefficient of the 
solute in the solution; A is the total amount of drug per unit 
volume; C
S is the solubility of drug in permeating dissolution 
fluid; ε is the porosity of the wall of microcapsule; J is the 
tortuosity  of  the  capillary  system  in  the  wall.  The  above 
equation can be simplified to Q = vt where v is the apparent 
release rate. 
i) Diffusion controlled monolithic system:  
Here  the  active  agent  is  released  by  diffusion  prior  to  or 
concurrent with the degradation of the polymer matrix. Rate 
of release also depend upon where the polymer degrades by 
homogeneous or heterogeneous mechanism. 
ii)  Diffusion controlled reservoir system:  
Here the active agent is encapsulated by a rate controlling 
membrane  through  which  the  agent  diffuses  and  the 
membrane erodes only after its delivery is completed. In this 
case,  drug  release  is  unaffected  by  the  degradation  of  the 
matrix. 
3. Osmosis: 
The  polymer  coat  of  microcapsule  acts  as  semi  permeable 
membrane  and  allows  the  creation  of  an  osmotic  pressure 
difference  between  the  inside  and  the  outside  of  the 
microcapsule  and  drives  drug  solution  out  of  the 
microcapsule through small pores in the coat. 
4. Erosion:  
Erosion  of  the  coat  due  to  pH  and  enzymatic  hydrolysis 
causes drug release with certain coat material like glyceryl 
mono stearate, beeswax and stearyl alcohol etc. 
Based  on  various  studies  concerning  the  release 
characteristics, the following generalizations can be made:  
1.  Drug  release  rate  from  microcapsules  conforming  to 
reservoir type is of zero order.  
2. Microcapsules of monolithic type and containing dissolved 
drug have release rates that are t
1/2 dependant for the first half 
of the total drug release and thereafter decline exponentially.  
3.  However,  if  a  monolithic  microcapsule  containing large 
excess  of  dissolved  drug, the release rate  is  essentially  t
1/2 
dependant throughout almost the entire drug release.  
In  monolithic  capsules  the  path  traveled  by  drug  is  not 
constant; the drug at the center travels a large distance than 
the drug at the surface. Therefore, the release rate generally 
decreases with time. 
25 
Applications of microcapsules and microspheres 
There  are  huge  numbers  of  applications  of 
microencapsulation; some of them are as follows: 
1.  Prolonged release dosage forms. The microencapsulated 
drug  can  be  administered,  as  microencapsulation  is 
perhaps  most  useful  for  the  preparation  of  tablets, 
capsules or parenteral dosage forms. 
2.  Microencapsulation can be used to prepare enteric-coated 
dosage forms, so that the medicament will be selectively 
absorbed in the intestine rather than the stomach.  
3.  It can be used to mask the taste of bitter drugs.  
4.  Microencapsulation has been used to overcome problems 
inherent  in  producing  tablets  from  tacky  granulations. 
This  was  done  by  improving  the  flow  properties.  For 
example, the non-flowable multicomponent solid mixture 
of niacin, riboflavin, and thiamine hydrochloride and iron 
phosphate  may  be  encapsulated  and  made  directly  into 
tablets. 
5.  It  has  been  used  to  protect  drugs  from  environmental 
hazards  such  as  humidity,  light,  oxygen  or  heat.  For 
example,  vitamin  A  and  K  have  been  shown  to  be 
protected  from  moisture  and  oxygen  through 
microencapsulation.
 26 
6.  The separations of incompatible substances, for example, 
pharmaceutical  eutectics  have  been  achieved  by 
encapsulation. The stability enhancement of incompatible 
aspirin-chlorpheniramine  maleate  mixture  was 
accomplished by microencapsulating both of them before 
mixing.
 27 
7.  Microencapsulation can be used to decrease the volatility.
 
28 
8.  Microencapsulation  has  also  been  used  to  decrease 
potential  danger  of  handling  of  toxic  or  noxious 
substances. 
29  
9.  The hygroscopic properties of many core materials may 
be reduced by microencapsulation.
 30  
10. Many  drugs  have  been  microencapsulated  to  reduce 
gastric irritation.  
11. Microencapsulation  method  has  also  been  proposed  to 
prepare intrauterine contraceptive device
.  
12. In the fabrication of multilayered tablet formulations for 
controlled  release  of  medicament  contained  in  medial 
layers of tableted particles. 
 
Table 1: Some microencapsulated drugs 
31,32 
Sl 
No. 
Drug material  Purpose  Product 
1  Acetaminophen  Taste masking.  Tablet 
2  Aspirin  Taste masking, sustained 
release, reduce gastric 
irritation & 
incompatibilities. 
Tablet or 
capsule 
3  Islet of 
Langerhans 
Sustained normalization of 
diabetic condition. 
Injectables 
4  Isosorbide 
dinitrate 
Sustained release capsules.  Capsules 
5  Menthol  Reduction of volatility.  Lotion 
6  Progesterone  Sustained release.  Varied 
7  Potassium 
chloride 
Reduced gastric irritation.  Capsules 
8  Urease  Perm selectivity of 
enzyme, substrate & and 
reaction product. 
Dispersion 
9  Vitamin A 
palmitate 
Stabilization to oxidation.  Dry powder 
10  5-fluorouracil  Reduced irritation.  Cream 
11  Retinol (pure)  Enhanced potency & 
reduced irritation. 
Cream 
(microsponge) 
12  Salicylic acid  Target particular area.  Microcrystal 
 
CONCLUSION  
Microencapsulation  refers  a  phenomenon  in  which  drug 
compounds  are  safely  encapsulated  as  a  small  capsule  in 
order  to  achieve  a  most  stable  product.  This  technology 
brings  a huge  impact  in  arena  of  pharmaceutical research, 
which also offers special appearance in controlled and target 
drug  delivery  system.  This  approach  is  not  only  able  to 
deliver the drug to target organ or tissue but also lowers drug 
concentration in other sites as well as minimizes the adverse 
effects of same drug. In other hand, it provides protection for 
labile compounds before and after administration and until it 
appears to the specified location for action.      
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